[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

$novo

Novo Nordisk's Wegovy gets FDA approval for liver disease, but the company is also cutting jobs. Investors are discussing the competition from Eli Lilly and potential manufacturing issues.

About $novo

Novo Nordisk (NOVO) is a pharmaceutical company focused on diabetes and obesity treatments.

Engagements: XXXXX #

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXX -XX%
1-Year High: XXXXXXX on 2025-08-07
1-Year Low: XX on 2025-10-15

Social Network	X
Engagements	XXXXX

Mentions: XX #

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
1-Year High: XX on 2025-07-30
1-Year Low: X on 2025-10-01

Social Network	X
Mentions	XX

Creators: XX #

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning $novo in the last XX hours which is up XX% from XX in the previous XX hours Daily Average: XX
1-Year High: XX on 2025-09-19
1-Year Low: X on 2025-10-01

The most influential creators that mention $novo in the last XX hours

Creator	Rank	Followers	Posts	Engagements
@INV44X	X	XX	X	XXXXX
@TheRayMyers	X	XXXXXX	X	XX

Sentiment: XX% #

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XX% no change
1 Month: XX% -XX%
1-Year High: XXX% on 2025-04-27
1-Year Low: XX% on 2025-10-07

Most Supportive Themes

FDA Approval for MASH: (40%) Novo Nordisk's Wegovy receives FDA approval for liver disease, boosting investor confidence.
Positive Outlook: (35%) Analysts and investors remain optimistic about Novo Nordisk's future.

Most Critical Themes

Manufacturing Concerns: (10%) Concerns about potential manufacturing issues for Novo Nordisk's injectable medications.
Competition from Eli Lilly: (15%) Mentions of Eli Lilly's competition in the weight loss and diabetes market.

Network engagement breakdown:

Network	Positive	%	Neutral	%	Negative	%
X	XXX	XX%	XXX	XX%	XXXXX	XX%

Total	XXX	XX%	XXX	XX%	XXXXX	XX%

Top assets mentioned In the posts about $novo in the last XX hours

Novo-Nordisk (NVO) Eli Lilly and Company (LLY) American Tower Corp (AMT) Constellation Brands, Inc. Class A (STZ) Akropolis (AKRO) Eli Lilly and Company (LLY) Bitfarms Ltd. (BITF) Vail Resorts, Inc. (MTN) Alphabet Inc Class A (GOOGL) Intellia Therapeutics, Inc (NTLA)

Top topics mentioned In the posts about $novo in the last XX hours